1800 202 8726
Drug costs and financial support

Alectinib Price in India: — Brand, Generic and Monthly Cost

Alectinib is available in India as branded Alecensa and as lower-cost generics from Indian manufacturers. The gap between the two is significant. This page sets out indicative monthly costs, explains where financial assistance is available, and tells you what to ask before your prescription is filled.

Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026

  • Generic is the same drug — Generic alectinib contains the same active molecule at the same strength as Alecensa — only the brand name and the price differ.
  • The cost gap is large — Indicative monthly costs range from around ₹50,000 for generics to several lakh for brand, as of H1 2025.
  • Patient assistance exists — Roche operates a patient access programme for Alecensa. Ask your oncologist before paying list price.
  • Insurance often excludes oral drugs — Many Indian health policies sub-limit or exclude oral chemotherapy. Verify your policy before the first dispensing.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get an indicative cost estimate

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Reviewed by a senior medical oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Alectinib is available in India as branded Alecensa and as lower-cost generics. Indicative monthly costs range from around ₹50,000 for generics to several lakh for brand, as of H1 2025. Your actual cost depends on which version is prescribed and whether you qualify for a patient access programme. All figures here are indicative — verify with your pharmacy.

What does alectinib cost per month in India?

OptionIndicative monthly cost (H1 2025)Notes
Branded Alecensa (Roche India)₹2–5 lakhIndicative. Verify current price with a licensed pharmacy.
Generic alectinib (Indian manufacturers)₹50,000–₹1.5 lakhMultiple brands available. Price varies by manufacturer.
Branded Alecensa via Roche access programmeReduced — amount varies by incomeApply through your oncologist or the CION team at your centre.
Private insurance reimbursementSubject to policy sub-limitsConfirm oral chemotherapy is covered before starting treatment.
Government scheme (PMJAY / CGHS / ECHS)Varies; check current scheme formularyAsk your hospital's insurance desk for current coverage status.

Why does generic alectinib cost less than Alecensa?

Alecensa was developed by Roche after years of research and clinical trials. The brand price reflects that investment. When the patent allows, or under a voluntary licence, Indian manufacturers can produce the same molecule using established processes at a much lower cost.

The active ingredient is identical. Generics sold in India go through CDSCO evaluation to confirm they match the reference product in how the drug is absorbed and behaves in the body.

Being prescribed a generic is not a downgrade. It is the standard way medicines become affordable once a therapy has been on the market for some years.

What will this actually cost you?

Costs depend on the regimen, the number of cycles and your scheme eligibility. Send your reports and we will give you an itemised, indicative estimate.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Know the cost before you commit

An itemised estimate, plus a check of which schemes you may qualify for.

Book Free Consultation Call 1800 202 8726

How can I reduce the cost of alectinib?

  1. Ask whether a generic can be prescribed

    Before your prescription is written, ask your oncologist specifically whether a generic version of alectinib is available and whether they are comfortable prescribing it. Many oncologists default to the brand unless asked directly.

  2. Apply to the Roche patient access programme

    Roche operates a programme for patients in India who cannot afford the listed price for Alecensa. Eligibility is income-based. Ask your oncologist for a referral, or ask the CION team at your centre — they can guide you through the paperwork.

  3. Check your insurance policy for oral chemotherapy cover

    Call your insurer before the first dispensing. Ask specifically whether oral targeted therapy is covered, what the annual sub-limit is, and what documentation is required for reimbursement. A denial after you have started treatment is much harder to resolve.

  4. Verify CGHS or ECHS entitlements if applicable

    Government employees and defence pensioners under CGHS or ECHS may find alectinib listed on their formulary. Confirm the current formulary at your CGHS wellness centre or ECHS polyclinic — do not assume coverage without checking the current list.

  5. Check PMJAY status at your hospital

    If you are enrolled in Pradhan Mantri Jan Arogya Yojana, ask your hospital's insurance desk whether alectinib is currently covered under the scheme's package list. Coverage is updated periodically, and a live check at the desk is more reliable than information from other sources.

What is different between brand Alecensa and a generic?

FeatureAlecensa (Roche)Generic alectinib (Indian brands)
Active moleculeAlectinib 150 mgAlectinib 150 mg
CDSCO regulatory approvalYes — reference productYes — bioequivalence demonstrated for each brand individually
Indicative monthly cost (H1 2025)₹2–5 lakh₹50,000–₹1.5 lakh
Patient assistance availableYes — Roche access programmeVaries by manufacturer; ask your pharmacist or oncologist
Appearance and packagingRoche-branded capsulesVaries by Indian manufacturer

What should I ask before my first prescription is filled?

Do not pay list price until you have asked about generics and whether you qualify for the Roche patient access programme. These questions take minutes; the savings can be substantial.

Ask the CION team at your centre to help you understand what is available near you and whether any assistance applies to your situation.

The figures on this page are indicative as of H1 2025. Drug prices change, scheme formularies are updated, and new generics enter the market. Always confirm the current price with a licensed pharmacy and your care coordinator before purchase.

Explore 75 more Lung Cancer Targeted Medicines topics

All Lung Cancer Targeted Medicines →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Is generic alectinib as effective as Alecensa?

Yes. Generic alectinib contains the same active molecule at the same strength as branded Alecensa. CDSCO requires all generics sold in India to demonstrate bioequivalence before approval — meaning the drug is absorbed and behaves the same way in the body as the reference product. The difference between brand and generic is the manufacturer and the price, not the medicine. Your oncologist can confirm which generics they are comfortable prescribing for your specific situation.

Can I switch from Alecensa to a generic mid-treatment?

In principle, yes — the active drug is the same. In practice, discuss any switch with your oncologist first. They will confirm which generic they are comfortable with and can ensure the dispensing pharmacy provides a consistent supply of the same generic going forward. Switching repeatedly between different generic manufacturers is not ideal, so once a switch is made it is better to stay with the same brand of generic rather than changing with each refill.

Does health insurance cover alectinib in India?

Some policies do, and many do not. Oral cancer medicines like alectinib are excluded or sub-limited by a large proportion of Indian health insurance plans. Check your policy document specifically for the terms around oral chemotherapy and targeted therapy. Call your insurer before your first prescription is filled — not after. If coverage is excluded, ask your oncologist about the Roche access programme and whether a generic brings the cost within reach.

Is alectinib covered under PMJAY?

Coverage under Pradhan Mantri Jan Arogya Yojana changes as the scheme's package list is updated. Check with your hospital's insurance desk or the PMJAY helpline, because listings change and new medicines are added periodically. Bring your PMJAY card and your prescription — the desk can run a live check on current coverage. Do not assume alectinib is covered or excluded without checking the current list.

How does the Roche patient access programme work?

Roche operates a programme in India for patients who cannot afford branded Alecensa at its listed price. Eligibility is assessed on household income and the treating oncologist's recommendation. The support offered can include significant price reductions or, for qualifying patients, free medicine. Your oncologist initiates the application, or you can ask the CION team at your centre to guide you through the process. Do not assume you are ineligible without applying — the criteria are broader than many patients expect.

Is alectinib on India's National List of Essential Medicines?

Alectinib was not on the NLEM as of the 2022 revision. Inclusion on the NLEM would cap the drug at a government-set price ceiling and significantly reduce cost. The list is reviewed periodically, and newer targeted therapies are increasingly being considered for addition. Check the current NLEM on the National Pharmaceutical Pricing Authority website, or ask your oncologist whether alectinib's status has changed since this page was last updated.

Call now Book free consultation